InvestorsHub Logo
Post# of 252642
Next 10
Followers 75
Posts 4700
Boards Moderated 0
Alias Born 09/06/2003

Re: DewDiligence post# 252541

Wednesday, 07/10/2024 10:03:47 AM

Wednesday, July 10, 2024 10:03:47 AM

Post# of 252642
OPT - listened to “KOL conference call” and amusingly they said approximately same things i did:

A) 3 letters better is ‘meh’ (so focus with patients should be on higher percent people getting 15 letters etc)

B) intent is to pair their drug w whatever existing treatment is being used. (Reminder: all existing treatments use a loading dose (multiple months of monthly dosing)

Were i getting treatment i wld do exactly as being described by the KOLs. I.e. Get the OPT treatment with loading, then “treat and extend” per label of the non-OPT treatment. It might get a little tricky with very long lasting treatments like OCUL’s, but given the very unpleasant process of injections… .

Amusing note: one of the KOLs looks and sounds like George Clooney!
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.